Recro Pharma, Inc. Business Finance Contracts & Agreements
69 Contracts & Agreements
- Assignment Agreements (1 contract)
- Credit Agreements (16)
- Escrow Agreements (6)
- Exchange Agreements (3)
- Investment Agreements (1)
- Investor Rights Agreements (1)
- Note Agreements (3)
- Purchase Agreements (6)
- Registration Rights Agreements (3)
- Security Agreements (1)
- Stock Agreements (15)
- Underwriting Agreements (5)
- Warrant Agreements (8)
- FIFTH AMENDMENT TO PURCHASE AND SALE AGREEMENT AND JOINT ESCROW INSTRUCTIONS (Filed With SEC on November 28, 2023)
- Fourth Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated October 3, 2023, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited... (Filed With SEC on November 8, 2023)
- Third Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated April 21, 2023, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited liability... (Filed With SEC on November 8, 2023)
- Second Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated January 23, 2023, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited... (Filed With SEC on November 8, 2023)
- First Amendment to Purchase and Sale Agreement and Joint Escrow Instructions, dated November 22, 2022, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited... (Filed With SEC on November 8, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on August 28, 2023)
- Underwriting Agreement, dated as of August 24, 2023, by and between Societal CDMO, Inc. and Craig-Hallum Capital Group, LLC, as representative of the underwriters (Filed With SEC on August 28, 2023)
- First Amendment to Subordinated Promissory Note (Filed With SEC on August 14, 2023)
- Common Stock Purchase Warrant in favor of IriSys, Inc (Filed With SEC on August 14, 2023)
- Common Stock Purchase Warrant in favor of Warberg WF XI LP (as assigned by OTA LLC) (Filed With SEC on August 14, 2023)
- Underwriting Agreement relating to the Preferred Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the... (Filed With SEC on December 13, 2022)
- Underwriting Agreement relating to the Common Offering, dated as of December 12, 2022, by and between Societal CDMO, Inc. and RBC Capital Markets, LLC, as representative of the... (Filed With SEC on December 13, 2022)
- Credit Agreement, dated as of December 12, 2022, by Societal CDMO, Inc. in favor of RBC Capital Markets, LLC (Filed With SEC on December 12, 2022)
- Purchase and Sale Agreement, dated as of December 9, 2022, by and between Societal CDMO Gainesville, LLC and Tenet Equity Funding SPE Gainesville, LLC (Filed With SEC on December 12, 2022)
- Purchase and Sale Agreement and Joint Escrow Instructions dated August 11, 2022, by and among Societal CDMO Gainesville, LLC, a Massachusetts limited liability company and Weekley... (Filed With SEC on August 16, 2022)
- Form of Subordinated Promissory Note (Filed With SEC on August 13, 2021)
- Unit Purchase Agreement, dated August 13, 2021, by and among Recro Pharma, Inc., IriSys, LLC, the Sellers (as defined therein), and IriSys, Inc. as the Sellers Representative (Filed With SEC on August 13, 2021)
- Form of Inducement Award Agreement for Restricted Stock Units (Filed With SEC on August 9, 2021)
- Form of Non-Qualified Stock Option Inducement Award Agreement (Filed With SEC on August 9, 2021)
- Underwriting Agreement, dated as of May 12, 2021, by and between Recro Pharma, Inc. and William Blair & Company, L.L.C., as representative of the underwriters (Filed With SEC on May 13, 2021)
- Second Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated February 26, 2021 (Filed With SEC on February 26, 2021)
- Form of Award Agreement for Restricted Stock Units (Filed With SEC on February 26, 2021)
- Form of Non-Qualified Stock Option Award Agreement (Filed With SEC on February 26, 2021)
- Stock Issuance Agreement, dated as of February 19, 2021 by and between Recro Pharma, Inc., Athyrium Opportunities II Acquisition LP and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)
- Fifth Amendment to Credit Agreement and Investment Documents, dated as of February 19, 2021, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)
- Fourth Amendment to Credit Agreement and Investment Documents, dated as of November 5, 2020, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 9, 2020)
- First Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated August 7, 2020 (Filed With SEC on August 10, 2020)
- Note dated May 12, 2020, between Recro Pharma, Inc. and PNC Bank, National Association (Filed With SEC on May 15, 2020)
- Partial Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and... (Filed With SEC on November 26, 2019)
- Third Amendment to Credit Agreement and Release Agreement, dated as of October 22, 2019, by and between Recro Pharma, Inc. and Athyrium Opportunities III Acquisition LP (Filed With SEC on November 8, 2019)
- Agreement, dated March 25, 2019, by and among Recro Pharma, Inc., Engine Capital, L.P., Engine Jet Capital, L.P., Engine Investments, LLC, and Arnaud Ajdler (Filed With SEC on March 28, 2019)
- Second Amendment to Credit Agreement and Investment Documents, dated February 28, 2019, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party... (Filed With SEC on March 4, 2019)
- Common Stock Purchase Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)
- Registration Rights Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)
- First Amendment to Credit Agreement and Investment Documents, dated December 28, 2018, by and among the Recro Pharma, Inc., the guarantors party thereto, the lenders party... (Filed With SEC on January 4, 2019)
- Second Amendment to Purchase and Sale Agreement, dated December 20, 2018, by and between Recro Pharma, Inc., Recro Gainesville LLC, Alkermes Pharma Ireland Limited, Daravita... (Filed With SEC on December 28, 2018)
- First Amendment to Warrant to Purchase Common Stock, dated December 20, 2018 (Filed With SEC on December 28, 2018)
- Common Stock Purchase Agreement, dated March 2, 2018, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on March 2, 2018)
- Seventh Amendment to Credit Agreement, dated as of December 9, 2022, by and among Societal CDMO, Inc., certain subsidiaries of Societal CDMO, Inc., named as guarantors therein,... (Filed With SEC on December 12, 2022)
- Sixth Amendment to Credit Agreement, dated as of August 13, 2021, by and among Recro Pharma, Inc., certain subsidiaries of Recro Pharma, Inc., named as guarantors therein, the... (Filed With SEC on August 13, 2021)
